367 related articles for article (PubMed ID: 11133880)
1. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.
Penn JS; Rajaratnam VS; Collier RJ; Clark AF
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):283-90. PubMed ID: 11133880
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of retinal neovascularization by intravitreal injection of human rPAI-1 in a rat model of retinopathy of prematurity.
Penn JS; Rajaratnam VS
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5423-9. PubMed ID: 14638747
[TBL] [Abstract][Full Text] [Related]
3. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
[TBL] [Abstract][Full Text] [Related]
4. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
5. The relationship of retinal VEGF and retinal IGF-1 mRNA with neovascularization in an acidosis-induced model of retinopathy of prematurity.
Leske DA; Wu J; Mookadam M; Chen Y; Fautsch MP; Holmes JM; Lanier WL
Curr Eye Res; 2006 Feb; 31(2):163-9. PubMed ID: 16500767
[TBL] [Abstract][Full Text] [Related]
6. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
7. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.
Barnett JM; McCollum GW; Fowler JA; Duan JJ; Kay JD; Liu RQ; Bingaman DP; Penn JS
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):907-15. PubMed ID: 17251494
[TBL] [Abstract][Full Text] [Related]
9. Angiostatic effect of penetrating ocular injury: role of pigment epithelium-derived factor.
Penn JS; McCollum GW; Barnett JM; Werdich XQ; Koepke KA; Rajaratnam VS
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):405-14. PubMed ID: 16384991
[TBL] [Abstract][Full Text] [Related]
10. The effect of L-thyroxine supplementation in a neonatal rat model of ROP.
Wren SM; Leske DA; Mutapcic L; Fautsch MP; Holmes JM
Curr Eye Res; 2006; 31(7-8):669-74. PubMed ID: 16877275
[TBL] [Abstract][Full Text] [Related]
11. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.
Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553
[TBL] [Abstract][Full Text] [Related]
12. Differences between rat strains in models of retinopathy of prematurity.
Floyd BN; Leske DA; Wren SM; Mookadam M; Fautsch MP; Holmes JM
Mol Vis; 2005 Jul; 11():524-30. PubMed ID: 16052168
[TBL] [Abstract][Full Text] [Related]
13. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
[TBL] [Abstract][Full Text] [Related]
14. The influence of triamcinolone on endostatin-like proteins in oxygen-induced retinopathy of prematurity.
May CA
Exp Eye Res; 2012 Jul; 100():86-7. PubMed ID: 22609274
[TBL] [Abstract][Full Text] [Related]
15. Experimental retinopathy of prematurity: angiostatic inhibition by nimodipine, ginkgo-biloba, and dipyridamole, and response to different growth factors.
Juárez CP; Muiño JC; Guglielmone H; Sambuelli R; Echenique JR; Hernández M; Luna JD
Eur J Ophthalmol; 2000; 10(1):51-9. PubMed ID: 10744206
[TBL] [Abstract][Full Text] [Related]
16. Abnormal panretinal response pattern to carbogen inhalation in experimental retinopathy of prematurity.
Berkowitz BA; Penn JS
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):840-5. PubMed ID: 9538894
[TBL] [Abstract][Full Text] [Related]
17. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
18. Neovascularization grading methods in a rat model of retinopathy of prematurity.
Zhang S; Leske DA; Holmes JM
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):887-91. PubMed ID: 10711709
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of retinal neovascularization by soluble EphA2 receptor.
Chen J; Hicks D; Brantley-Sieders D; Cheng N; McCollum GW; Qi-Werdich X; Penn J
Exp Eye Res; 2006 Apr; 82(4):664-73. PubMed ID: 16359662
[TBL] [Abstract][Full Text] [Related]
20. Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP.
Berkowitz BA; Zhang W
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1925-31. PubMed ID: 10845618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
